Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
Clinical trial NCT07493304 · RECRUITING
Trial details
- NCT number
- NCT07493304
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2031-07-08
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.